Endothelin and the renal vasculature

Endothelin in Renal Physiology and Disease

Volumn 172, Issue , 2011, Pages 35-49

  Guan, Zhengrong ^a   Inscho, Edward W ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; ENDOTHELIN; ENDOTHELIN RECEPTOR;

ANIMAL; HEMODYNAMICS; HOMEOSTASIS; HUMAN; HYPERTENSION; KIDNEY; METABOLISM; MICROCIRCULATION; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; VASCULARIZATION;

ANIMALS; CALCIUM; ENDOTHELINS; HEMODYNAMICS; HOMEOSTASIS; HUMANS; HYPERTENSION; KIDNEY; MICROCIRCULATION; RECEPTORS, ENDOTHELIN;

EID: 84926129469     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1159/000328720     Document Type: Chapter

References (74)

1. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K, Masaki T: A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988;332:411-415.
2. Inoue A, Yanagisawa M, Kimura S, Kasuya Y, Miyauchi T, Goto K, Masaki T: The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separate genes. Proc Natl Acad Sci USA 1989;86:2863-2867.
3. Sakurai T, Yanagisawa M, Takuwa Y, Miyazaki H, Kimura S, Goto K, Masaki T: Cloning of a cDNA encoding a nonisopeptide-selective subtype of the endothelin receptor. Nature 1990;348:732-735.
4. Simonson MS: Endothelins: multifunctional renal peptides. Physiol Rev 1993;73:375-411.
5. Kohan DE, Rossi NF, Inscho EW, Pollock DM: Regulation of blood pressure and salt homeostasis by endothelin. Physiol Rev 2011;91:1-77.
6. Wagner OF, Christ G, Wojta J, Vierhapper H, Parzer S, Nowotny PJ, Schneider B, Waldhausl W, Binder BR: Polar secretion of endothelin-1 by cultured endothelial cells. J Biol Chem 1992;267:16066-16068.
7. Treiber FA, Jackson RW, Davis H, Pollock JS, Kapuku G, Mensah GA, Pollock DM: Racial differences in endothelin-1 at rest and in response to acute stress in adolescent males. Hypertension 2000;35:722-725.
8. Kitamura K, Tanaka T, Kato J, Ogawa T, Eto T, Tanaka K: Immunoreactive endothelin in rat kidney inner medulla: marked decrease in spontaneously hypertensive rats. Biochem Biophys Res Commun 1989;162:38-44.
9. Matsuura T, Miura K, Ebara T, Yukimura T, Yamanaka S, Kim S, Iwao H: Renal vascular effects of the selective endothelin receptor antagonists in anaesthetized rats. Br J Pharmacol 1997;122:81-86.
10. Fukuroda T, Fujikawa T, Ozaki S, Ishikawa K, Yano M, Nishikibe M: Clearance of circulating endothelin-1 by ETB receptors in rats. Biochem Biophys Res Commun 1994;199:1461-1465.
11. Bagnall AJ, Kelland NF, Gulliver-Sloan F, Davenport AP, Gray GA, Yanagisawa M, Webb DJ, Kotelevtsev YV: Deletion of endothelial cell endothelin B receptors does not affect blood pressure or sensitivity to salt. Hypertension 2006;48:286-293.
12. Brooks DP, DePalma PD, Pullen M, Nambi P: Characterization of canine renal endothelin receptor subtypes and their function. J Pharmacol Exp Ther 1994;268:1091-1097.
13. Gellai M, DeWolf R, Pullen M, Nambi P:Distribution and functional role of renal ET receptor subtypes in normotensive and hypertensive rats. Kidney Int 1994;46:1287-1294.
14. Waeber C, Hoyer D, Palacios JM: Similar distribution of [125I]sarafotoxin-6b and [125I]endothelin-1, -2, -3 binding sites in the human kidney. Eur J Pharmacol 1990;176:233-236.
15. Johnstrom P, Rudd JH, Richards HK, Fryer TD, Clark JC, Weissberg PL, Pickard JD, Davenport AP: Imaging endothelin ETB receptors using [18F]-BQ3020:in vitro characterization and positron emission tomography (microPET). Exp Biol Med 2006;231:736-740.
16. Nambi P, Pullen M, Wu HL, Aiyar N, Ohlstein EH, Edwards RM: Identification of endothelin receptor subtypes in human renal cortex and medulla using subtype-selective ligands. Endocrinology 1992;131:1081-1086.
17. Wendel M, Knels L, Kummer W, Koch T:Distribution of endothelin receptor subtypes ETA and ETB in the rat kidney. J Histochem Cytochem 2006;54:1193-1203.
18. Edwards RM, Trizna W: Characterization of 125I-endothelin-1 binding to rat and rabbit renal microvasculature. J Pharmacol Exp Ther 1995;274:1084-1089.
19. De Leon H, Garcia R: Characterization of endothelin receptor subtypes in isolated rat renal preglomerular microvessels. Regul Pept 1995;60:1-8.
20. Kuc R, Davenport AP: Comparison of endothelin-A and endothelin-B receptor distribution visualized by radioligand binding versus immunocytochemical localization using subtype selective antisera. J Cardiovasc Pharmacol 2004;44(Suppl 1):S224-S226.
21. Davenport AP, Kuc RE, Maguire JJ, Harland SP: ETA receptors predominate in the human vasculature and mediate constriction. J Cardiovasc Pharmacol 1995;26(Suppl 3):S265-S267.
22. Clozel M, Clozel JP: Effects of endothelin on regional blood flows in squirrel monkeys. J Pharmacol Exp Ther 1989;250:1125-1131.
23. King AJ, Brenner BM, Anderson S:Endothelin: a potent renal and systemic vasoconstrictor peptide. Am J Physiol Renal Physiol 1989;256:F1051-1058.
24. Loutzenhiser R, Epstein M, Hayashi K, Horton C: Direct visualization of effects of endothelin on the renal microvasculature. Am J Physiol Renal Physiol 1990;258:F61-F68.
25. Evans RG, Bergstrom G, Cotterill E, Anderson WP: Renal haemodynamic effects of endothelin-1 and the ETA/ETB antagonist TAK-044 in anaesthetized rabbits. J Hypertens 1998;16:1897-1905.
26. Evans RG, Madden AC, Oliver JJ, Lewis TV:Effects of ETA-and ETB-receptor antagonists on regional kidney blood flow, and responses to intravenous endothelin-1, in anaesthetized rabbits. J Hypertens 2001;19:1789-1799.
27. Pollock DM, Opgenorth TJ: Evidence for endothelin-induced renal vasoconstriction independent of ETA receptor activation. Am J Physiol Regul Integr Comp Physiol 1993;264:R222-R226.
28. Cristol JP, Warner TD, Thiemermann C, Vane JR: Mediation via different receptors of the vasoconstrictor effects of endothelins and sarafotoxins in the systemic circulation and renal vasculature of the anaesthetized rat. Br J Pharmacol 1993;108:776-779.
29. Gellai M, Fletcher T, Pullen M, Nambi P:Evidence for the existence of endothelin-B receptor subtypes and their physiological roles in the rat. Am J Physiol Regul Integr Comp Physiol 1996;271, R254-R261.
30. Just A, Olson AJ, Arendshorst WJ: Dual constrictor and dilator actions of ETB receptors in the rat renal microcirculation: interactions with ETA receptors. Am J Physiol Renal Physiol 2004;286, F660-F668.
31. Wellings RP, Corder R, Warner TD, Cristol JP, Thiemermann C, Vane JR: Evidence from receptor antagonists of an important role for ETB receptor-mediated vasoconstrictor effects of endothelin-1 in the rat kidney. Br J Pharmacol 1994;111:515-520.
32. Denton KM, Shweta A, Finkelstein L, Flower RL, Evans RG: Effect of endothelin-1 on regional kidney blood flow and renal arteriole calibre in rabbits. Clin Exp Pharmacol Physiol 2004;31:494-501.
33. Vassileva I, Mountain C, Pollock DM:Functional role of ETB receptors in the renal medulla. Hypertension 2003;41:1359-1363.
34. Brodsky S, Abassi Z, Wessale J, Ramadan R, Winaver J, Hoffman A: Effects of A-192621.1, a specific endothelin-B antagonist, on intrarenal hemodynamic responses to endothelin-1. J Cardiovasc Pharmacol 2000;36:S311-S313.
35. Hercule HC, Oyekan AO: Role of NO and cytochrome P-450-derived eicosanoids in ET-1-induced changes in intrarenal hemodynamics in rats. Am J Physiol Regul Integr Comp Physiol 2000;279:R2132-R2141.
36. Casellas D, Navar LG: In vitro perfusion of juxtamedullary nephrons in rats. Am J Physiol Renal Physiol 1984;246:F349-F358.
37. Imig JD, Pham BT, LeBlanc EA, Reddy KM, Falck JR, Inscho EW: Cytochrome P450 and cyclooxygenase metabolites contribute to the endothelin-1 afferent arteriolar vasoconstrictor and calcium responses. Hypertension 2000;35:307-312.
38. Inscho EW, Imig JD, Cook AK, Pollock DM: ETA and ETB receptors differentially modulate afferent and efferent arteriolar responses to endothelin. Br J Pharmacol 2005;146:1019-1026.
39. Pollock DM, Jenkins JM, Cook AK, Imig JD, Inscho EW: L-type calcium channels in the renal microcirculatory response to endothelin. Am J Physiol Renal Physiol 2005;288:F771-F777.
40. Schneider MP, Inscho EW, Pollock DM:Attenuated vasoconstrictor responses to endothelin in afferent arterioles during a high-salt diet. Am J Physiol Renal Physiol 2007;292:F1208-F 1214.
41. Kon V, Yoshioka T, Fogo A, Ichikawa I:Glomerular actions of endothelin in vivo. J Clin Invest 1989;83:1762-1767.
42. Takenaka T, Forster H, Epstein M: Protein kinase C and calcium channel activation as determinants of renal vasoconstriction by angiotensin II and endothelin. Circ Res 1993;73:743-750.
43. Saito M, Homma S, Yamatsu I, Sato M, Ohshima N: Visualization of renal microcirculation in isolated Munich-Wistar rat kidneys: effects of endothelin-1 on renal hemodynamic activity. Jpn J Pharmacol 1994;66:221-229.
44. Lanese DM, Yuan BH, McMurtry IF, Conger JD: Comparative sensitivities of isolated rat renal arterioles to endothelin. Am J Physiol Renal Physiol 1992;263:F894-F899.
45. Schildroth J, Rettig-Zimmermann J, Kalk P, Steege A, Fahling M, Sendeski M, Paliege A, Lai EY, Bachmann S, Persson PB, Hocher B, Patzak A: Endothelin type A and B receptors in the control of afferent and efferent arterioles in mice. Nephrol Dial Transplant 2011;26:779-789.
46. Kisanuki YY, Emoto N, Ohuchi T, Widyantoro B, Yagi K, Nakayama K, Kedzierski RM, Hammer RE, Yanagisawa H, Williams SC, Richardson JA, Suzuki T, Yanagisawa M: Low blood pressure in endothelial cell-specific endothelin 1 knockout mice. Hypertension 2010;56:121-128.
47. Pallone TL, Zhang Z, Rhinehart K:Physiology of the renal medullary microcirculation. Am J Physiol Renal Physiol 2003;284:F253-F 266.
48. Qiu C, Samsell L, Baylis C: Actions of endogenous endothelin on glomerular hemodynamics in the rat. Am J Physiol Regul Integr Comp Physiol 1995;269:R469-R473.
49. Navar LG, Arendshorst WJ, Pallone TL, Inscho EW, Imig JD, Bell PD:Microcirculation; in Tuma RFD, Wa LK (eds): Handbook of Physiology 2008. San Diego, Elsevier, p.550-683.
50. Takabatake T, Ise T, Ohta K, Kobayashi K:Effects of endothelin on renal hemodynamics and tubuloglomerular feedback. Am J Physiol Renal Physiol 1992;263:F103-F 108.
51. Berthold H, Munter K, Just A, Kirchheim HR, Ehmke H: Contribution of endothelin to renal vascular tone and autoregulation in the conscious dog. Am J Physiol Renal Physiol 1999;276:F417-F424.
52. Kramp R, Fourmanoir P, Caron N:Endothelin resets renal blood flow autoregulatory efficiency during acute blockade of NO in the rat. Am J Physiol Renal Physiol 2001;281:F1132-F1140.
53. Shi Y, Lau C, Cupples WA: Interactive modulation of renal myogenic autoregulation by nitric oxide and endothelin acting through ETB receptors. Am J Physiol Regul Integr Comp Physiol 2007;292:R354-R361.
54. Romano G, Giagu P, Favret G, Bartoli E:Effect of endothelin 1 on proximal reabsorption and tubuloglomerular feedback. Kidney Blood Press Res 2000;23:360-365.
55. Schroeder AC, Imig JD, LeBlanc EA, Pham BT, Pollock DM, Inscho EW: Endothelinmediated calcium signaling in preglomerular smooth muscle cells. Hypertension 2000;35:280-286.
56. Fretschner M, Endlich K, Gulbins E, Lang RE, Schlottmann K, Steinhausen M: Effects of endothelin on the renal microcirculation of the split hydronephrotic rat kidney. Ren Physiol Biochem 1991;14:112-127.
57. Madeddu P, Yang XP, Anania V, et al:Efficacy of nifedipine to prevent systemic and renal vasoconstrictor effects of endothelin. Am J Physiol 1990;259:F304-F311.
58. Yukimura T, Miura K, Yamashita Y, Shimmen T, Okumura M, Yamanaka S, Saito M, Yamamoto K: Effects of the calcium channel antagonist nicardipine on renal action of endothelin in dogs. Contrib Nephrol 1991;90:105-110.
59. Takahashi K, Katoh T, Fukunaga M, Badr KF:Studies on the glomerular microcirculatory actions of manidipine and its modulation of the systemic and renal effects of endothelin. Am Heart J 1993;125:609-619.
60. Edwards RM, Trizna W, Ohlstein EH: Renal microvascular effects of endothelin. Am J Physiol Renal Physiol 1990;259:F217-F 221.
61. Fellner SK, Arendshorst W: Endothelin-A and -B receptors, superoxide, and Ca2+ signaling in afferent arterioles. Am J Physiol Renal Physiol 2007;292:F175-F184.
62. Thai TL, Churchill GC, Arendshorst WJ:NAADP receptors mediate calcium signaling stimulated by endothelin-1 and norepinephrine in renal afferent arterioles. Am J Physiol Renal Physiol 2009;297:F510-F 516.
63. Cavarape A, Endlich N, Assaloni R, Bartoli E, Steinhausen M, Parekh N, Endlich K: Rhokinase inhibition blunts renal vasoconstriction induced by distinct signaling pathways in vivo. J Am Soc Nephrol 2003;14:37-45.
64. Just A, Whitten CL, Arendshorst WJ:Reactive oxygen species participate in acute renal vasoconstrictor responses induced by ETA and ETB receptors. Am J Physiol Renal Physiol 2008;294:F719-F 728.
65. Just A, Olson AJ, Falck JR, Arendshorst WJ: NO and NO-independent mechanisms mediate ETB receptor buffering of ET-1-induced renal vasoconstriction in the rat. Am J Physiol Regul Integr Comp Physiol 2005;288:R1168-R1177.
66. Hirata Y, Matsuoka H, Kimura K, Sugimoto T, Hayakawa H, Suzuki E, Sugimoto T: Role of endothelium-derived relaxing factor in endothelin-induced renal vasoconstriction. J Cardiovasc Pharmacol 1991;17(Suppl 7):S169-S171.
67. Chou SY, Porush JG: Renal actions of endothelin-1 and endothelin-3: interactions with the prostaglandin system and nitric oxide. Am J Kidney Dis 1995;26:116-123.
68. Cao LQ, Banks RO: Cardiorenal actions of endothelin, part II: effects of cyclooxygenase inhibitors. Life Sci 1990;46:585-590.
69. Duval M, D'Orleans-Juste P: Endothelin-1 induces an endothelin-A-receptor-dependent and L-NAME-sensitive vasoconstriction in the isolated perfused guinea-pig kidney. J Cardiovasc Pharmacol 2000;36:S241-S 243.
70. Munger KA, Takahashi K, Awazu M, Frazer M, Falk SA, Conger JD, Badr KF:Maintenance of endothelin-induced renal arteriolar constriction in rats is cyclooxygenase dependent. Am J Physiol 1993;264:F637-F 644.
71. Bouallegue A, Daou GB, Srivastava AK:Endothelin-1-induced signaling pathways in vascular smooth muscle cells. Curr Vasc Pharmacol 2007;5:45-52.
72. Kedzierski RM, Yanagisawa M: Endothelin system: the double-edged sword in health and disease. Annu Rev Pharmacol Toxicol 2001;41:851-876.
73. Simchon S, Manger WM, Carlin RD, Peeters LL, Rodriguez J, Batista D, Brown T, Merchant NB, Jan KM, Chien S: Saltinduced hypertension in Dahl salt-sensitive rats. Hemodynamics and renal responses. Hypertension 1989;13:612-621.
74. Barton M, Vos I, Shaw S, Boer P, D'Uscio LV, Grone HJ, Rabelink TJ, Lattmann T, Moreau P, Luscher TF: Dysfunctional renal nitric oxide synthase as a determinant of salt-sensitive hypertension: mechanisms of renal artery endothelial dysfunction and role of endothelin for vascular hypertrophy and Glomerulosclerosis. J Am Soc Nephrol 2000;11:835-845.